Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия
  • Бизнес
  • Functional Area Sort ascending
  • Дата
Длъжност Място Местоположение дивизия Бизнес Functional Area Sort ascending Дата
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Септ. 11, 2024
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Септ. 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Септ. 11, 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others Окт. 22, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Май 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Май 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Май 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others Май 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) France Innovative Medicines Others Май 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Май 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Май 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others Май 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Юни 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) France People & Organization Innovative Medicines Others Юли 04, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Авг. 19, 2024
Next Generation Scientist 2025 Basel (City) Switzerland Biomedical Research Innovative Medicines Others Окт. 01, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Окт. 10, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Септ. 13, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Окт. 16, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Окт. 17, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Окт. 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Окт. 18, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Окт. 15, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Окт. 16, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 23, 2024
Record to Report Sr. Specialist USA INSURGENTES Mexico Finance CTS Audit & Finance Окт. 23, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Audit & Finance Окт. 24, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Окт. 22, 2024
Senior Financial Analyst - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Окт. 22, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 23, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Окт. 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 23, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance Май 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Юни 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Юни 20, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Юли 03, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Юли 22, 2024
SAP Security Manager Prague Czech Republic Operations CTS Audit & Finance Юли 22, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Юли 28, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Юли 05, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit & Finance Юли 17, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Септ. 25, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Окт. 02, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Окт. 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Окт. 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Окт. 08, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България